Published in Clinical Trials Week, August 16th, 2004
The Swiss authorities, Swissmedic, have already granted PEGASYS 'fast track' review status. The approval in Switzerland would also allow for approvals in approximately 80 other countries that depend on prior Swiss approval.
Roche filed PEGASYS for the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.